See more : Maj Invest – Maj Invest Vækstaktier KL (MAJVA.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Mediclinic International plc (MDC.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mediclinic International plc, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Financial Institutions, Inc. (FISI) Income Statement Analysis – Financial Results
- Wedge Industrial Co.,Ltd. (000534.SZ) Income Statement Analysis – Financial Results
- International Distributions Services plc (IDS.L) Income Statement Analysis – Financial Results
- Optics Technology Holding Co.,Ltd (300489.SZ) Income Statement Analysis – Financial Results
- Natural Beauty Bio-Technology Limited (0157.HK) Income Statement Analysis – Financial Results
Mediclinic International plc (MDC.L)
About Mediclinic International plc
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.23B | 3.00B | 3.08B | 2.93B | 2.87B | 2.75B | 2.11B | 1.96B | 1.73B | 1.75B | 1.79B | 1.70B | 1.54B | 1.20B | 594.43M | 375.27M | 442.24M | 342.15M | 314.10M | 234.00M | 150.94M |
Cost of Revenue | 2.73B | 2.57B | 1.96B | 1.83B | 1.77B | 1.70B | 1.26B | 1.11B | 973.82M | 986.03M | 1.00B | 940.87M | 860.02M | 681.27M | 333.92M | 204.85M | 240.74M | 189.38M | 176.47M | 135.64M | 85.58M |
Gross Profit | 505.00M | 426.00M | 1.12B | 1.11B | 1.10B | 1.05B | 843.00M | 853.59M | 753.83M | 763.26M | 787.66M | 756.01M | 679.89M | 521.43M | 260.51M | 170.43M | 201.50M | 152.77M | 137.64M | 98.37M | 65.35M |
Gross Profit Ratio | 15.62% | 14.22% | 36.43% | 37.69% | 38.22% | 38.30% | 40.01% | 43.56% | 43.63% | 43.63% | 43.99% | 44.55% | 44.15% | 43.36% | 43.83% | 45.41% | 45.56% | 44.65% | 43.82% | 42.04% | 43.30% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 799.00M | 780.00M | 1.39B | 689.00M | 554.00M | 451.29M | 371.76M | 388.43M | 407.43M | 374.64M | 397.53M | 319.38M | 153.71M | 100.04M | 120.60M | 92.59M | 84.27M | 58.79M | 38.46M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 799.00M | 780.00M | 1.39B | 689.00M | 554.00M | 451.29M | 371.76M | 388.43M | 407.43M | 374.64M | 397.53M | 319.38M | 153.71M | 100.04M | 120.60M | 92.59M | 84.27M | 58.79M | 38.46M |
Other Expenses | 215.00M | 215.00M | -3.00M | -13.00M | -15.00M | -14.00M | -7.00M | 8.79M | 113.31K | -142.44K | -2.12M | 1.18M | 0.00 | 0.00 | 0.00 | 0.00 | 10.58M | 6.72M | 0.00 | 0.00 | 313.28K |
Operating Expenses | 215.00M | 215.00M | 799.00M | 780.00M | 1.39B | 689.00M | 554.00M | 535.36M | 441.95M | 462.50M | 481.53M | 441.87M | 397.53M | 319.38M | 153.71M | 100.04M | 128.56M | 92.59M | 84.27M | 58.79M | 38.46M |
Cost & Expenses | 2.94B | 2.78B | 2.76B | 2.61B | 3.16B | 2.39B | 1.82B | 1.64B | 1.42B | 1.45B | 1.48B | 1.38B | 1.26B | 1.00B | 487.63M | 304.89M | 369.30M | 281.97M | 260.73M | 194.42M | 124.05M |
Interest Income | 6.00M | 4.00M | 9.00M | 9.00M | 9.00M | 7.00M | 9.00M | 5.73M | 4.14M | 4.84M | 6.92M | 5.56M | 3.68M | 4.93M | 3.04M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 62.00M | 63.00M | 80.00M | 55.00M | 61.00M | 69.00M | 55.00M | 51.88M | 56.09M | 92.66M | 133.72M | 135.84M | 136.91M | 117.83M | 42.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 235.00M | 217.00M | 217.00M | 168.00M | -25.00M | 145.00M | 93.00M | 84.07M | 70.19M | 71.15M | 74.11M | 67.24M | 64.50M | 50.31M | 3.04M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | 515.00M | 357.00M | 332.00M | 323.00M | -315.00M | 363.00M | 292.00M | 414.92M | 373.40M | 352.96M | 385.11M | 388.48M | 351.18M | 257.44M | 109.84M | 70.38M | 72.94M | 60.18M | 53.37M | 39.58M | 26.89M |
EBITDA Ratio | 15.93% | 11.92% | 10.77% | 11.02% | -10.98% | 13.20% | 13.86% | 21.18% | 21.61% | 20.18% | 21.51% | 22.89% | 22.80% | 21.41% | 18.48% | 18.75% | 16.49% | 17.59% | 16.99% | 16.92% | 17.82% |
Operating Income | 280.00M | 140.00M | 115.00M | 155.00M | -290.00M | 362.00M | 288.00M | 318.23M | 311.88M | 303.68M | 306.12M | 314.14M | 282.36M | 202.06M | 106.80M | 70.38M | 72.94M | 60.18M | 53.37M | 39.58M | 26.89M |
Operating Income Ratio | 8.66% | 4.67% | 3.73% | 5.29% | -10.10% | 13.17% | 13.67% | 16.24% | 18.05% | 17.36% | 17.10% | 18.51% | 18.34% | 16.80% | 17.97% | 18.75% | 16.49% | 17.59% | 16.99% | 16.92% | 17.82% |
Total Other Income/Expenses | -69.00M | -69.00M | -484.00M | -430.00M | -218.00M | 595.00M | -43.00M | -43.00M | -71.10M | -333.31M | -128.83M | -128.74M | -164.38M | -52.30M | -17.50M | -39.43M | 7.58M | 8.82M | 2.72M | 3.62M | 1.61M |
Income Before Tax | 211.00M | 104.00M | -275.00M | -137.00M | -479.00M | 307.00M | 245.00M | 263.62M | 247.12M | -21.44M | 177.29M | 185.40M | 149.76M | 89.30M | 67.33M | 67.37M | 80.53M | 69.00M | 56.09M | 43.21M | 28.50M |
Income Before Tax Ratio | 6.53% | 3.47% | -8.92% | -4.67% | -16.69% | 11.17% | 11.63% | 13.45% | 14.30% | -1.23% | 9.90% | 10.93% | 9.73% | 7.42% | 11.33% | 17.95% | 18.21% | 20.17% | 17.86% | 18.46% | 18.88% |
Income Tax Expense | 41.00M | 25.00M | 24.00M | -7.00M | -5.00M | 64.00M | 55.00M | 11.45M | 43.96M | 31.48M | 56.44M | 59.58M | 43.21M | 36.92M | 22.59M | 18.89M | 40.08M | 17.84M | -15.00M | -11.61M | -7.82M |
Net Income | 151.00M | 68.00M | -299.00M | -130.00M | -474.00M | 229.00M | 177.00M | 238.93M | 191.77M | -71.36M | 120.85M | 125.82M | 106.55M | 52.37M | 44.74M | 48.48M | 40.45M | 51.15M | 41.09M | 31.60M | 20.69M |
Net Income Ratio | 4.67% | 2.27% | -9.70% | -4.43% | -16.52% | 8.33% | 8.40% | 12.19% | 11.10% | -4.08% | 6.75% | 7.41% | 6.92% | 4.35% | 7.53% | 12.92% | 9.15% | 14.95% | 13.08% | 13.50% | 13.70% |
EPS | 0.21 | 0.09 | -0.41 | -0.18 | -0.64 | 0.31 | 0.30 | 0.45 | 0.24 | -0.10 | 0.15 | 0.18 | 0.17 | 0.08 | 0.09 | 0.11 | 0.09 | 0.13 | 0.11 | 0.09 | 0.05 |
EPS Diluted | 0.21 | 0.09 | -0.41 | -0.18 | -0.64 | 0.31 | 0.30 | 0.44 | 0.23 | -0.09 | 0.14 | 0.17 | 0.16 | 0.08 | 0.08 | 0.10 | 0.08 | 0.13 | 0.11 | 0.08 | 0.05 |
Weighted Avg Shares Out | 737.24M | 737.24M | 737.21M | 737.19M | 737.11M | 736.94M | 598.44M | 540.27M | 812.08M | 741.86M | 679.15M | 602.47M | 568.72M | 559.34M | 421.44M | 357.61M | 347.14M | 342.37M | 340.84M | 341.63M | 348.76M |
Weighted Avg Shares Out (Dil) | 737.29M | 737.24M | 737.21M | 737.24M | 737.24M | 737.24M | 599.21M | 550.23M | 829.72M | 762.86M | 703.65M | 629.49M | 598.66M | 591.00M | 455.75M | 394.11M | 392.42M | 346.75M | 345.75M | 345.93M | 353.71M |
Source: https://incomestatements.info
Category: Stock Reports